News-Medical.Net on MSN
Study reveals the global economic costs of diabetes
Diabetes mellitus is a chronic metabolic disorder and one of the most prevalent non-communicable diseases worldwide.
The International Diabetes Federation officially recognized a fifth form of the disease this year, a landmark step that comes ...
Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...
News-Medical.Net on MSN
Diabetes could drain up to INT$78.8 trillion from the global economy by 2050, study finds
This global macroeconomic analysis estimates that diabetes mellitus will cost the world economy INT$10.2 trillion between ...
ScienceAlert on MSN
A Distinct New Type of Diabetes Is Officially Recognized
This year, the International Diabetes Federation (IDF) officially recognized a fifth form of diabetes, after decades of ...
The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.
Verywell Health on MSN
Diabetes insipidus vs. diabetes mellitus: What’s the difference?
Medically reviewed by Danielle Weiss, MD Key Takeaways Diabetes insipidus affects the kidneys and water balance, not blood ...
Among 8- to 9-year-olds, those with vs. without maternal gestational diabetes mellitus exposure had two reduced measures of ...
Patients with type 1 diabetes mellitus or type 2 diabetes mellitus (T2DM) have an increased risk of fractures; BMD underestimates this risk in individuals with T2DM, making risk assessment challenging ...
Diabetes mellitus could drain tens of trillions from the global economy, with informal caregiving emerging as the largest ...
Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results